Friday, November 13, 2009

Migraine Home>
News>
FDA approves Cambia + potassium bicarbonate for migraine

Font size
- A
- A
- A
Email This

Bookmark

Save

FDA approves Cambia + potassium bicarbonate for migraine

(Doctor's Guide News) UPDATED 2009-06-23

The U.S. Food and Drug Administration has approved an oral solution that combines the anti-inflammatory Cambia plus potassium bicarbonate for the treatment of migraine. In recent studies, the drug was found to be effective in treating migraine as well as migraine complications such as photophobia, phonophobia, and nausea. Experts say it helped patients in as little as fifteen minutes after the onset of symptoms. Read full story >

See all Migraine News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyMigraineConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.